Publikationen, an denen er mitarbeitet JOSÉ MARÍA ALUSTIZA ECHEBERRIA (19)

2021

  1. Adiponectin, Leptin, and IGF-1 Are Useful Diagnostic and Stratification Biomarkers of NAFLD

    Frontiers in Medicine, Vol. 8

  2. Prediction of liver iron overload in the Basque country (Spain) in patients referred for hyperferritinemia

    Digestive and Liver Disease

2020

  1. Body mass index and alcohol consumption are directly related with liver steatosis. Results from a prospective study of patients referred for hyperferritinemia

    Annals of Hepatology

  2. Liver iron concentration in dysmetabolic hyperferritinemia: Results from a prospective cohort of 276 patients

    Annals of Hepatology, Vol. 19, Núm. 1, pp. 31-35

2017

  1. Dysmetabolic iron overload syndrome: The need for an accurate liver iron concentration determination by magnetic resonance imaging

    Hepatology

  2. Liver Iron concentration in patients referred to a secondary hospital for hyperferritinemia: Analysis of the different groups according to HFE mutations and the transferrin saturation index

    Hepatitis Monthly, Vol. 17, Núm. 1, pp. 1-5

2016

  1. Liver iron concentration is not raised in patients with dysmetabolic hyperferritinemia

    Annals of Hepatology, Vol. 15, Núm. 4, pp. 540-544

  2. PNPLA3 p.I148M variant is associated with greater reduction of liver fat content after bariatric surgery

    Surgery for Obesity and Related Diseases, Vol. 12, Núm. 10, pp. 1838-1846

2015

  1. Impact of H63D mutations, magnetic resonance and metabolic syndrome among outpatient referrals for elevated serum ferritin in the Basque Country

    Annals of Hepatology, Vol. 14, Núm. 3, pp. 333-339

2014

  1. Novel equation to determine the hepatic triglyceride concentration in humans by MRI: Diagnosis and monitoring of NAFLD in obese patients before and after bariatric surgery

    BMC Medicine, Vol. 12, Núm. 1

2012

  1. Accurate fat fraction quantification by multiecho gradient-recalled-echo magnetic resonance at 1.5 T in rats with nonalcoholic fatty liver disease

    European Journal of Radiology, Vol. 81, Núm. 6, pp. 1122-1127

  2. Effect of neoadjuvant chemotherapy in hepatic steatosis

    Chemotherapy, Vol. 58, Núm. 2, pp. 89-94

  3. Is the role of liver biopsy changing in hemochromatosis? a non invasive approach is ready

    Journal of Gastrointestinal and Liver Diseases

  4. Mild hepatic iron overload in dysmetabolic hyperferritinemia: MRI may overestimate the liver iron concentration values

    Annals of Hematology

  5. ¿cómo establecer la hipótesis y los objetivos de un proyecto de investigación en Radiología?

    Radiologia, Vol. 54, Núm. 1, pp. 3-8

2011

  1. Características clínicas y evolutivas de una familia con hemocromatosis hereditaria tipo 1

    Gaceta Medica de Bilbao, Vol. 108, Núm. 2, pp. 42-48

2010

  1. Are hepatocellular carcinoma surveillance programs effective at improving the therapeutic options?

    Revista Espanola de Enfermedades Digestivas, Vol. 102, Núm. 8, pp. 484-488

2008

  1. Cuantificación de la concentración de hierro en hígado mediante RM de 1 Tesla

    Radiologia, Vol. 50, Núm. 4, pp. 303-307

  2. Diagnosis and quantification of iron overload in the liver using MRI

    Radiologia, Vol. 50, Núm. 1, pp. 29-36